EPIDEMIOLOGY AND INFECTION-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2118159, encodeId=b99121181594c, content=请问这个期刊meta好投吗？国人友好吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1338436238, createdName=ms6000001812813546, createdTime=Tue Mar 07 18:22:23 CST 2023, time=2023-03-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1225198, encodeId=09c21225198e9, content=有没有小伙伴可以分享一下投稿进程，投稿快一个月还是Awaiting Referee Selection，这样正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Wed Jun 08 14:52:26 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572799, encodeId=c4d15e2799b9, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：Submitted Decisioned 08-Dec-2018 27-Mar-2019 revise 14-Apr-2019 04-Jun-2019 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0b35119169, createdName=llxs666_44370781, createdTime=Sat Jun 22 14:57:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588715, encodeId=2234588e1529, content=收到回复，大修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/gePpre4TKyDaBvMvicUPEDianXEXBbGbF8MuPO3ibwyVYJib1BW6ouamOLDVEEiaicicT4ych7DCf9h4O9YB0o63LLpFQ/132, createdBy=f1551701216, createdName=sunmonica502788, createdTime=Sun Apr 12 00:00:00 CST 2020, time=2020-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090141, encodeId=81001090141b5, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090142, encodeId=a1791090142c6, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800720, encodeId=e13c800e2047, content=审稿速度:2.0 经验分享：请教一下，有没有近期接受的同志，这个杂志的版面费是多少啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/20/b6889fb7121b7e80e307e46da7b48aa5.jpg, createdBy=230c1700433, createdName=小哼, createdTime=Wed Jul 01 08:58:38 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132910, encodeId=d2c0213291048, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：三月初提交，四月初就返回来了审稿意见，审稿人和编辑非常友好，目前已经录取啦~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1338436238, createdName=ms6000001812813546, createdTime=Fri May 12 15:37:18 CST 2023, time=2023-05-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123521, encodeId=34ff212352189, content=请问大家这个杂志是一次返修只有一位审稿人吗？前两天发现状态变成了major revision，点开那个view decision letter之后发现里面reviewer(s) comments to author里面只有refree1的意见，这是啥意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1338436238, createdName=ms6000001812813546, createdTime=Mon Apr 03 17:13:36 CST 2023, time=2023-04-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1224688, encodeId=94f812246881b, content=请问这个状态是什么意思？Awaiting Referee Selection, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Mon Jun 06 10:25:28 CST 2022, time=2022-06-06, status=1, ipAttribution=)]

2023-03-07 ms6000001812813546 来自北京

请问这个期刊meta好投吗？国人友好吗？

31 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2118159, encodeId=b99121181594c, content=请问这个期刊meta好投吗？国人友好吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1338436238, createdName=ms6000001812813546, createdTime=Tue Mar 07 18:22:23 CST 2023, time=2023-03-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1225198, encodeId=09c21225198e9, content=有没有小伙伴可以分享一下投稿进程，投稿快一个月还是Awaiting Referee Selection，这样正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Wed Jun 08 14:52:26 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572799, encodeId=c4d15e2799b9, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：Submitted Decisioned 08-Dec-2018 27-Mar-2019 revise 14-Apr-2019 04-Jun-2019 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0b35119169, createdName=llxs666_44370781, createdTime=Sat Jun 22 14:57:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588715, encodeId=2234588e1529, content=收到回复，大修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/gePpre4TKyDaBvMvicUPEDianXEXBbGbF8MuPO3ibwyVYJib1BW6ouamOLDVEEiaicicT4ych7DCf9h4O9YB0o63LLpFQ/132, createdBy=f1551701216, createdName=sunmonica502788, createdTime=Sun Apr 12 00:00:00 CST 2020, time=2020-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090141, encodeId=81001090141b5, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090142, encodeId=a1791090142c6, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800720, encodeId=e13c800e2047, content=审稿速度:2.0 经验分享：请教一下，有没有近期接受的同志，这个杂志的版面费是多少啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/20/b6889fb7121b7e80e307e46da7b48aa5.jpg, createdBy=230c1700433, createdName=小哼, createdTime=Wed Jul 01 08:58:38 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132910, encodeId=d2c0213291048, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：三月初提交，四月初就返回来了审稿意见，审稿人和编辑非常友好，目前已经录取啦~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1338436238, createdName=ms6000001812813546, createdTime=Fri May 12 15:37:18 CST 2023, time=2023-05-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123521, encodeId=34ff212352189, content=请问大家这个杂志是一次返修只有一位审稿人吗？前两天发现状态变成了major revision，点开那个view decision letter之后发现里面reviewer(s) comments to author里面只有refree1的意见，这是啥意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1338436238, createdName=ms6000001812813546, createdTime=Mon Apr 03 17:13:36 CST 2023, time=2023-04-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1224688, encodeId=94f812246881b, content=请问这个状态是什么意思？Awaiting Referee Selection, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Mon Jun 06 10:25:28 CST 2022, time=2022-06-06, status=1, ipAttribution=)]

2022-06-08 小花🌸

有没有小伙伴可以分享一下投稿进程，投稿快一个月还是Awaiting Referee Selection，这样正常吗？

44 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2118159, encodeId=b99121181594c, content=请问这个期刊meta好投吗？国人友好吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1338436238, createdName=ms6000001812813546, createdTime=Tue Mar 07 18:22:23 CST 2023, time=2023-03-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1225198, encodeId=09c21225198e9, content=有没有小伙伴可以分享一下投稿进程，投稿快一个月还是Awaiting Referee Selection，这样正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Wed Jun 08 14:52:26 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572799, encodeId=c4d15e2799b9, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：Submitted Decisioned 08-Dec-2018 27-Mar-2019 revise 14-Apr-2019 04-Jun-2019 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0b35119169, createdName=llxs666_44370781, createdTime=Sat Jun 22 14:57:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588715, encodeId=2234588e1529, content=收到回复，大修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/gePpre4TKyDaBvMvicUPEDianXEXBbGbF8MuPO3ibwyVYJib1BW6ouamOLDVEEiaicicT4ych7DCf9h4O9YB0o63LLpFQ/132, createdBy=f1551701216, createdName=sunmonica502788, createdTime=Sun Apr 12 00:00:00 CST 2020, time=2020-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090141, encodeId=81001090141b5, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090142, encodeId=a1791090142c6, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800720, encodeId=e13c800e2047, content=审稿速度:2.0 经验分享：请教一下，有没有近期接受的同志，这个杂志的版面费是多少啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/20/b6889fb7121b7e80e307e46da7b48aa5.jpg, createdBy=230c1700433, createdName=小哼, createdTime=Wed Jul 01 08:58:38 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132910, encodeId=d2c0213291048, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：三月初提交，四月初就返回来了审稿意见，审稿人和编辑非常友好，目前已经录取啦~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1338436238, createdName=ms6000001812813546, createdTime=Fri May 12 15:37:18 CST 2023, time=2023-05-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123521, encodeId=34ff212352189, content=请问大家这个杂志是一次返修只有一位审稿人吗？前两天发现状态变成了major revision，点开那个view decision letter之后发现里面reviewer(s) comments to author里面只有refree1的意见，这是啥意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1338436238, createdName=ms6000001812813546, createdTime=Mon Apr 03 17:13:36 CST 2023, time=2023-04-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1224688, encodeId=94f812246881b, content=请问这个状态是什么意思？Awaiting Referee Selection, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Mon Jun 06 10:25:28 CST 2022, time=2022-06-06, status=1, ipAttribution=)]

2019-06-22 llxs666_44370781

审稿速度:6.0 | 投稿命中率:75.0
经验分享：Submitted Decisioned
08-Dec-2018 27-Mar-2019 revise
14-Apr-2019 04-Jun-2019 accept

129 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2118159, encodeId=b99121181594c, content=请问这个期刊meta好投吗？国人友好吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1338436238, createdName=ms6000001812813546, createdTime=Tue Mar 07 18:22:23 CST 2023, time=2023-03-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1225198, encodeId=09c21225198e9, content=有没有小伙伴可以分享一下投稿进程，投稿快一个月还是Awaiting Referee Selection，这样正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Wed Jun 08 14:52:26 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572799, encodeId=c4d15e2799b9, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：Submitted Decisioned 08-Dec-2018 27-Mar-2019 revise 14-Apr-2019 04-Jun-2019 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0b35119169, createdName=llxs666_44370781, createdTime=Sat Jun 22 14:57:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588715, encodeId=2234588e1529, content=收到回复，大修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/gePpre4TKyDaBvMvicUPEDianXEXBbGbF8MuPO3ibwyVYJib1BW6ouamOLDVEEiaicicT4ych7DCf9h4O9YB0o63LLpFQ/132, createdBy=f1551701216, createdName=sunmonica502788, createdTime=Sun Apr 12 00:00:00 CST 2020, time=2020-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090141, encodeId=81001090141b5, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090142, encodeId=a1791090142c6, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800720, encodeId=e13c800e2047, content=审稿速度:2.0 经验分享：请教一下，有没有近期接受的同志，这个杂志的版面费是多少啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/20/b6889fb7121b7e80e307e46da7b48aa5.jpg, createdBy=230c1700433, createdName=小哼, createdTime=Wed Jul 01 08:58:38 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132910, encodeId=d2c0213291048, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：三月初提交，四月初就返回来了审稿意见，审稿人和编辑非常友好，目前已经录取啦~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1338436238, createdName=ms6000001812813546, createdTime=Fri May 12 15:37:18 CST 2023, time=2023-05-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123521, encodeId=34ff212352189, content=请问大家这个杂志是一次返修只有一位审稿人吗？前两天发现状态变成了major revision，点开那个view decision letter之后发现里面reviewer(s) comments to author里面只有refree1的意见，这是啥意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1338436238, createdName=ms6000001812813546, createdTime=Mon Apr 03 17:13:36 CST 2023, time=2023-04-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1224688, encodeId=94f812246881b, content=请问这个状态是什么意思？Awaiting Referee Selection, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Mon Jun 06 10:25:28 CST 2022, time=2022-06-06, status=1, ipAttribution=)]

2020-04-12 sunmonica502788

收到回复，大修

151 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2118159, encodeId=b99121181594c, content=请问这个期刊meta好投吗？国人友好吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1338436238, createdName=ms6000001812813546, createdTime=Tue Mar 07 18:22:23 CST 2023, time=2023-03-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1225198, encodeId=09c21225198e9, content=有没有小伙伴可以分享一下投稿进程，投稿快一个月还是Awaiting Referee Selection，这样正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Wed Jun 08 14:52:26 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572799, encodeId=c4d15e2799b9, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：Submitted Decisioned 08-Dec-2018 27-Mar-2019 revise 14-Apr-2019 04-Jun-2019 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0b35119169, createdName=llxs666_44370781, createdTime=Sat Jun 22 14:57:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588715, encodeId=2234588e1529, content=收到回复，大修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/gePpre4TKyDaBvMvicUPEDianXEXBbGbF8MuPO3ibwyVYJib1BW6ouamOLDVEEiaicicT4ych7DCf9h4O9YB0o63LLpFQ/132, createdBy=f1551701216, createdName=sunmonica502788, createdTime=Sun Apr 12 00:00:00 CST 2020, time=2020-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090141, encodeId=81001090141b5, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090142, encodeId=a1791090142c6, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800720, encodeId=e13c800e2047, content=审稿速度:2.0 经验分享：请教一下，有没有近期接受的同志，这个杂志的版面费是多少啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/20/b6889fb7121b7e80e307e46da7b48aa5.jpg, createdBy=230c1700433, createdName=小哼, createdTime=Wed Jul 01 08:58:38 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132910, encodeId=d2c0213291048, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：三月初提交，四月初就返回来了审稿意见，审稿人和编辑非常友好，目前已经录取啦~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1338436238, createdName=ms6000001812813546, createdTime=Fri May 12 15:37:18 CST 2023, time=2023-05-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123521, encodeId=34ff212352189, content=请问大家这个杂志是一次返修只有一位审稿人吗？前两天发现状态变成了major revision，点开那个view decision letter之后发现里面reviewer(s) comments to author里面只有refree1的意见，这是啥意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1338436238, createdName=ms6000001812813546, createdTime=Mon Apr 03 17:13:36 CST 2023, time=2023-04-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1224688, encodeId=94f812246881b, content=请问这个状态是什么意思？Awaiting Referee Selection, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Mon Jun 06 10:25:28 CST 2022, time=2022-06-06, status=1, ipAttribution=)]

2021-12-27 msSSSSSD

引言和讨论的区别？

64 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2118159, encodeId=b99121181594c, content=请问这个期刊meta好投吗？国人友好吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1338436238, createdName=ms6000001812813546, createdTime=Tue Mar 07 18:22:23 CST 2023, time=2023-03-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1225198, encodeId=09c21225198e9, content=有没有小伙伴可以分享一下投稿进程，投稿快一个月还是Awaiting Referee Selection，这样正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Wed Jun 08 14:52:26 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572799, encodeId=c4d15e2799b9, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：Submitted Decisioned 08-Dec-2018 27-Mar-2019 revise 14-Apr-2019 04-Jun-2019 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0b35119169, createdName=llxs666_44370781, createdTime=Sat Jun 22 14:57:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588715, encodeId=2234588e1529, content=收到回复，大修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/gePpre4TKyDaBvMvicUPEDianXEXBbGbF8MuPO3ibwyVYJib1BW6ouamOLDVEEiaicicT4ych7DCf9h4O9YB0o63LLpFQ/132, createdBy=f1551701216, createdName=sunmonica502788, createdTime=Sun Apr 12 00:00:00 CST 2020, time=2020-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090141, encodeId=81001090141b5, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090142, encodeId=a1791090142c6, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800720, encodeId=e13c800e2047, content=审稿速度:2.0 经验分享：请教一下，有没有近期接受的同志，这个杂志的版面费是多少啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/20/b6889fb7121b7e80e307e46da7b48aa5.jpg, createdBy=230c1700433, createdName=小哼, createdTime=Wed Jul 01 08:58:38 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132910, encodeId=d2c0213291048, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：三月初提交，四月初就返回来了审稿意见，审稿人和编辑非常友好，目前已经录取啦~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1338436238, createdName=ms6000001812813546, createdTime=Fri May 12 15:37:18 CST 2023, time=2023-05-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123521, encodeId=34ff212352189, content=请问大家这个杂志是一次返修只有一位审稿人吗？前两天发现状态变成了major revision，点开那个view decision letter之后发现里面reviewer(s) comments to author里面只有refree1的意见，这是啥意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1338436238, createdName=ms6000001812813546, createdTime=Mon Apr 03 17:13:36 CST 2023, time=2023-04-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1224688, encodeId=94f812246881b, content=请问这个状态是什么意思？Awaiting Referee Selection, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Mon Jun 06 10:25:28 CST 2022, time=2022-06-06, status=1, ipAttribution=)]

2021-12-29 衣谷

怎么撰写引言？区别于讨论？

58 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2118159, encodeId=b99121181594c, content=请问这个期刊meta好投吗？国人友好吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1338436238, createdName=ms6000001812813546, createdTime=Tue Mar 07 18:22:23 CST 2023, time=2023-03-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1225198, encodeId=09c21225198e9, content=有没有小伙伴可以分享一下投稿进程，投稿快一个月还是Awaiting Referee Selection，这样正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Wed Jun 08 14:52:26 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572799, encodeId=c4d15e2799b9, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：Submitted Decisioned 08-Dec-2018 27-Mar-2019 revise 14-Apr-2019 04-Jun-2019 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0b35119169, createdName=llxs666_44370781, createdTime=Sat Jun 22 14:57:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588715, encodeId=2234588e1529, content=收到回复，大修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/gePpre4TKyDaBvMvicUPEDianXEXBbGbF8MuPO3ibwyVYJib1BW6ouamOLDVEEiaicicT4ych7DCf9h4O9YB0o63LLpFQ/132, createdBy=f1551701216, createdName=sunmonica502788, createdTime=Sun Apr 12 00:00:00 CST 2020, time=2020-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090141, encodeId=81001090141b5, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090142, encodeId=a1791090142c6, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800720, encodeId=e13c800e2047, content=审稿速度:2.0 经验分享：请教一下，有没有近期接受的同志，这个杂志的版面费是多少啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/20/b6889fb7121b7e80e307e46da7b48aa5.jpg, createdBy=230c1700433, createdName=小哼, createdTime=Wed Jul 01 08:58:38 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132910, encodeId=d2c0213291048, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：三月初提交，四月初就返回来了审稿意见，审稿人和编辑非常友好，目前已经录取啦~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1338436238, createdName=ms6000001812813546, createdTime=Fri May 12 15:37:18 CST 2023, time=2023-05-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123521, encodeId=34ff212352189, content=请问大家这个杂志是一次返修只有一位审稿人吗？前两天发现状态变成了major revision，点开那个view decision letter之后发现里面reviewer(s) comments to author里面只有refree1的意见，这是啥意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1338436238, createdName=ms6000001812813546, createdTime=Mon Apr 03 17:13:36 CST 2023, time=2023-04-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1224688, encodeId=94f812246881b, content=请问这个状态是什么意思？Awaiting Referee Selection, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Mon Jun 06 10:25:28 CST 2022, time=2022-06-06, status=1, ipAttribution=)]

2020-07-01 小哼

审稿速度:2.0
经验分享：请教一下，有没有近期接受的同志，这个杂志的版面费是多少啊？

155 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2118159, encodeId=b99121181594c, content=请问这个期刊meta好投吗？国人友好吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1338436238, createdName=ms6000001812813546, createdTime=Tue Mar 07 18:22:23 CST 2023, time=2023-03-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1225198, encodeId=09c21225198e9, content=有没有小伙伴可以分享一下投稿进程，投稿快一个月还是Awaiting Referee Selection，这样正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Wed Jun 08 14:52:26 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572799, encodeId=c4d15e2799b9, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：Submitted Decisioned 08-Dec-2018 27-Mar-2019 revise 14-Apr-2019 04-Jun-2019 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0b35119169, createdName=llxs666_44370781, createdTime=Sat Jun 22 14:57:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588715, encodeId=2234588e1529, content=收到回复，大修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/gePpre4TKyDaBvMvicUPEDianXEXBbGbF8MuPO3ibwyVYJib1BW6ouamOLDVEEiaicicT4ych7DCf9h4O9YB0o63LLpFQ/132, createdBy=f1551701216, createdName=sunmonica502788, createdTime=Sun Apr 12 00:00:00 CST 2020, time=2020-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090141, encodeId=81001090141b5, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090142, encodeId=a1791090142c6, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800720, encodeId=e13c800e2047, content=审稿速度:2.0 经验分享：请教一下，有没有近期接受的同志，这个杂志的版面费是多少啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/20/b6889fb7121b7e80e307e46da7b48aa5.jpg, createdBy=230c1700433, createdName=小哼, createdTime=Wed Jul 01 08:58:38 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132910, encodeId=d2c0213291048, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：三月初提交，四月初就返回来了审稿意见，审稿人和编辑非常友好，目前已经录取啦~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1338436238, createdName=ms6000001812813546, createdTime=Fri May 12 15:37:18 CST 2023, time=2023-05-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123521, encodeId=34ff212352189, content=请问大家这个杂志是一次返修只有一位审稿人吗？前两天发现状态变成了major revision，点开那个view decision letter之后发现里面reviewer(s) comments to author里面只有refree1的意见，这是啥意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1338436238, createdName=ms6000001812813546, createdTime=Mon Apr 03 17:13:36 CST 2023, time=2023-04-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1224688, encodeId=94f812246881b, content=请问这个状态是什么意思？Awaiting Referee Selection, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Mon Jun 06 10:25:28 CST 2022, time=2022-06-06, status=1, ipAttribution=)]

2023-05-12 ms6000001812813546 来自北京

审稿速度:3.0 | 投稿命中率:75.0
经验分享：三月初提交，四月初就返回来了审稿意见，审稿人和编辑非常友好，目前已经录取啦~

34 0

[GetPortalCommentsPageByObjectIdResponse(id=2118159, encodeId=b99121181594c, content=请问这个期刊meta好投吗？国人友好吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1338436238, createdName=ms6000001812813546, createdTime=Tue Mar 07 18:22:23 CST 2023, time=2023-03-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1225198, encodeId=09c21225198e9, content=有没有小伙伴可以分享一下投稿进程，投稿快一个月还是Awaiting Referee Selection，这样正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Wed Jun 08 14:52:26 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572799, encodeId=c4d15e2799b9, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：Submitted Decisioned 08-Dec-2018 27-Mar-2019 revise 14-Apr-2019 04-Jun-2019 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0b35119169, createdName=llxs666_44370781, createdTime=Sat Jun 22 14:57:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588715, encodeId=2234588e1529, content=收到回复，大修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/gePpre4TKyDaBvMvicUPEDianXEXBbGbF8MuPO3ibwyVYJib1BW6ouamOLDVEEiaicicT4ych7DCf9h4O9YB0o63LLpFQ/132, createdBy=f1551701216, createdName=sunmonica502788, createdTime=Sun Apr 12 00:00:00 CST 2020, time=2020-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090141, encodeId=81001090141b5, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090142, encodeId=a1791090142c6, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800720, encodeId=e13c800e2047, content=审稿速度:2.0 经验分享：请教一下，有没有近期接受的同志，这个杂志的版面费是多少啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/20/b6889fb7121b7e80e307e46da7b48aa5.jpg, createdBy=230c1700433, createdName=小哼, createdTime=Wed Jul 01 08:58:38 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132910, encodeId=d2c0213291048, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：三月初提交，四月初就返回来了审稿意见，审稿人和编辑非常友好，目前已经录取啦~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1338436238, createdName=ms6000001812813546, createdTime=Fri May 12 15:37:18 CST 2023, time=2023-05-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123521, encodeId=34ff212352189, content=请问大家这个杂志是一次返修只有一位审稿人吗？前两天发现状态变成了major revision，点开那个view decision letter之后发现里面reviewer(s) comments to author里面只有refree1的意见，这是啥意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1338436238, createdName=ms6000001812813546, createdTime=Mon Apr 03 17:13:36 CST 2023, time=2023-04-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1224688, encodeId=94f812246881b, content=请问这个状态是什么意思？Awaiting Referee Selection, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Mon Jun 06 10:25:28 CST 2022, time=2022-06-06, status=1, ipAttribution=)]

2023-04-03 ms6000001812813546 来自北京

请问大家这个杂志是一次返修只有一位审稿人吗？前两天发现状态变成了major revision，点开那个view decision letter之后发现里面reviewer(s) comments to author里面只有refree1的意见，这是啥意思啊？

43 0

[GetPortalCommentsPageByObjectIdResponse(id=2118159, encodeId=b99121181594c, content=请问这个期刊meta好投吗？国人友好吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1338436238, createdName=ms6000001812813546, createdTime=Tue Mar 07 18:22:23 CST 2023, time=2023-03-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1225198, encodeId=09c21225198e9, content=有没有小伙伴可以分享一下投稿进程，投稿快一个月还是Awaiting Referee Selection，这样正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Wed Jun 08 14:52:26 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572799, encodeId=c4d15e2799b9, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：Submitted Decisioned 08-Dec-2018 27-Mar-2019 revise 14-Apr-2019 04-Jun-2019 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0b35119169, createdName=llxs666_44370781, createdTime=Sat Jun 22 14:57:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588715, encodeId=2234588e1529, content=收到回复，大修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/gePpre4TKyDaBvMvicUPEDianXEXBbGbF8MuPO3ibwyVYJib1BW6ouamOLDVEEiaicicT4ych7DCf9h4O9YB0o63LLpFQ/132, createdBy=f1551701216, createdName=sunmonica502788, createdTime=Sun Apr 12 00:00:00 CST 2020, time=2020-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090141, encodeId=81001090141b5, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090142, encodeId=a1791090142c6, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800720, encodeId=e13c800e2047, content=审稿速度:2.0 经验分享：请教一下，有没有近期接受的同志，这个杂志的版面费是多少啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/20/b6889fb7121b7e80e307e46da7b48aa5.jpg, createdBy=230c1700433, createdName=小哼, createdTime=Wed Jul 01 08:58:38 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132910, encodeId=d2c0213291048, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：三月初提交，四月初就返回来了审稿意见，审稿人和编辑非常友好，目前已经录取啦~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1338436238, createdName=ms6000001812813546, createdTime=Fri May 12 15:37:18 CST 2023, time=2023-05-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123521, encodeId=34ff212352189, content=请问大家这个杂志是一次返修只有一位审稿人吗？前两天发现状态变成了major revision，点开那个view decision letter之后发现里面reviewer(s) comments to author里面只有refree1的意见，这是啥意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1338436238, createdName=ms6000001812813546, createdTime=Mon Apr 03 17:13:36 CST 2023, time=2023-04-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1224688, encodeId=94f812246881b, content=请问这个状态是什么意思？Awaiting Referee Selection, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Mon Jun 06 10:25:28 CST 2022, time=2022-06-06, status=1, ipAttribution=)]

2022-06-06 小花🌸

请问这个状态是什么意思？Awaiting Referee Selection

96 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务